Abstract
BACKGROUND: The spread of microbial resistance to antibiotics is a recent global problem, which has become more acute in recent years because of a significant increase in the consumption of antibiotics, against the background of the COVID-19 pandemic. A direct consequence of the spread of antibiotic-insensitive strains of pneumococci limits the treatment options for such patients and deterioration of the prognosis.
AIM: To determine whether sex is a factor associated with the development of diseases caused by antibiotic-resistant strains of Streptococcus pneumoniae.
MATERIALS AND METHODS: Using the electronic databases PubMed, ScienceDirect, and Google Scholar, a search was conducted for articles published from January 1980 to December 2020, and studies in English and Russian were selected. The selection of articles and meta-analysis was based on the recommendations of the PRISMA Group and MOOSE. After combining the data, the odds ratio (OR) was calculated with a 95% confidence interval (95% CI). Heterogeneity was assessed.
RESULTS: After applying the exclusion criteria, 41 publications covering 16635 patients with invasive and non-invasive forms of pneumococcal infection were selected for analysis. Of these, 36 case-control studies and 5 cross-sectional studies were identified. Accordingly, the sex of the patient does not affect the frequency of isolation of pneumococcal strains insensitive to penicillin (odds ratio [OR]=0.92, 95% confidence interval [CI] 0.821.03, I2=7%), resistant to penicillin (OR=0.85, 95% CI 0.671.07, I2=1%), and insensitive to erythromycin (OR=0.80, 95% CI 0.511.24, I2=0%). Male sex is associated with pneumococcal resistance to levofloxacin (OR=1.85, 95% CI 1.033.33, I2=0%).
CONCLUSIONS: The sex of the patient is not a factor associated with the isolation of S. pneumonia strains insensitive and resistant to penicillin and erythromycin. Moreover, the male sex probably increases the chance of isolation of levofloxacin-resistant pneumococci in adults with invasive pneumococcal infections.
Subject
Building and Construction
Reference65 articles.
1. Progress in introduction of pneumococcal conjugate vaccine worldwide, 2000–2012. Wkly Epidemiol. 2013;88(17):173–180.
2. Mayansky NA, Alyabyeva NM, Lazareva MA, et al. Antibiotic sensitivity, clonal and gray typical diversity of pneumococci in children with acute otitis media in Moscow. Clinical Microbiology and Antimicrobial Chemotherapy. 2016;18(2):84–92. (In Russ).
3. Factors Associated With Antimicrobial Resistance and Mortality in Pneumococcal Bacteremia
4. Impact of COVID-19 on pneumonia-focused antibiotic use at an academic medical center
5. Antibiotic Consumption and Stewardship at a Hospital outside of an Early Coronavirus Disease 2019 Epicenter